dalotuzumab - CISMeF

Preferred Label : dalotuzumab;

MeSH note : in phase I clinical trials (2010) for treatment of cancer;

CISMeF synonym : MK 0646;

MeSH hyponym : MK0646; MK-0646;

Is substance : O;

UNII : 6YI1L648RH;

Détails

Origin ID

C569480;

UMLS CUI

C2987605;

Currated CISMeF NLP mapping
- Dalotuzumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- MK 0646 [MeSH concept]
- dalotuzumab [MeSH concept]
See also (suggested by CISMeF)
- IGF1R protein, human [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dalotuzumab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients